| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.048 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |